Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid Users
This study has been completed.
Study NCT01030406   Information provided by Acura Pharmaceuticals Inc.

First Received on December 10, 2009.   Last Updated on March 8, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Opioid Abuse
Interventions listed in this trial
Drug A
Drug B
Drug C
Drug D
Placebo
Additional drug interventions recognized in this trial
Analgesics, Opioid
More general drug interventions related to this trial
Analgesics
Central Nervous System Agents
Central Nervous System Depressants
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Acura Pharmaceuticals Inc.
King Pharmaceuticals is now a wholly owned subsidiary of Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services